Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

Total article views   HTML views PDF downloads Totals
6,889 Dovepress* 6,729+ 1,217 7,946
PubMed Central* 160 67 227
Totals 6,889 1,284 8,173
*Since 27 September 2017

View citations on PubMed Central and Google Scholar